BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 22580608)

  • 1. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
    Ahlqvist K; Saamarthy K; Syed Khaja AS; Bjartell A; Massoumi R
    Oncogene; 2013 Mar; 32(12):1601-8. PubMed ID: 22580608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the NF-кB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma.
    de Souza Braga M; da Silva Paiva KB; Foguer K; Barbosa Chaves KC; de Sá Lima L; Scavone C; Bellini MH
    Biomed Pharmacother; 2014 Sep; 68(7):873-9. PubMed ID: 25113400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-3 regulates UVB-induced apoptosis.
    García I; Cosío G; Lizárraga F; Martínez-Ruiz G; Meléndez-Zajgla J; Ceballos G; Espinosa M; Pacheco R; Maldonado V
    Hum Cell; 2013 Jun; 26(2):47-55. PubMed ID: 23494744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells.
    Saamarthy K; Ahlqvist K; Daams R; Balagunaseelan N; Rinaldo-Matthis A; Kazi JU; Sime W; Massoumi R
    BMC Cancer; 2024 Jan; 24(1):103. PubMed ID: 38238702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age.
    Seaton G; Smith H; Brancale A; Westwell AD; Clarkson R
    Mol Cancer; 2024 Jan; 23(1):7. PubMed ID: 38195591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Metabolism and Metabolic Pathways in Prostate Cancer.
    Wanjari UR; Mukherjee AG; Gopalakrishnan AV; Murali R; Dey A; Vellingiri B; Ganesan R
    Metabolites; 2023 Jan; 13(2):. PubMed ID: 36837801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.
    Heo J; Lee J; Nam YJ; Kim Y; Yun H; Lee S; Ju H; Ryu CM; Jeong SM; Lee J; Lim J; Cho YM; Jeong EM; Hong B; Son J; Shin DM
    Exp Mol Med; 2022 Jun; 54(6):801-811. PubMed ID: 35729325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple roles for Bcl-3 in mammary gland branching, stromal collagen invasion, involution and tumor pathology.
    Carr D; Zein A; Coulombe J; Jiang T; Cabrita MA; Ward G; Daneshmand M; Sau A; Pratt MAC
    Breast Cancer Res; 2022 Jun; 24(1):40. PubMed ID: 35681213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-Related
    Xiao Z; Zhao H
    Pharmgenomics Pers Med; 2022; 15():157-165. PubMed ID: 35241926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma.
    Wang X; Zhao Y; Fei X; Lu Q; Li Y; Yuan Y; Lu C; Li C; Chen H
    Int J Biol Sci; 2020; 16(13):2392-2404. PubMed ID: 32760207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Bcl-3 Expression on Cell Migration and Chemosensitivity of Gastric Cancer Cells via Regulating Hypoxia-Induced Protective Autophagy.
    Hu L; Bai Z; Ma X; Bai N; Zhang Z
    J Gastric Cancer; 2020 Mar; 20(1):95-105. PubMed ID: 32269848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of hepatitis B virus X protein-induced aberrant microRNA expression to hepatocellular carcinoma pathogenesis.
    Wei Z; Shen X; Ni B; Luo G; Tian Y; Sun Y
    Turk J Biol; 2019; 43(2):113-123. PubMed ID: 31320813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
    Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC
    Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis.
    Ke J; Wu R; Chen Y; Abba ML
    Am J Transl Res; 2018; 10(12):3887-3910. PubMed ID: 30662638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications.
    Staal J; Beyaert R
    Cells; 2018 Aug; 7(9):. PubMed ID: 30158439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence.
    Puccio I; Khan S; Butt A; Graham D; Sehgal V; Patel D; Novelli M; Lovat LB; Rodriguez-Justo M; Hamoudi RA
    Int J Exp Pathol; 2018 Feb; 99(1):10-14. PubMed ID: 29473241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation signatures in peripheral blood strongly predict all-cause mortality.
    Zhang Y; Wilson R; Heiss J; Breitling LP; Saum KU; Schöttker B; Holleczek B; Waldenberger M; Peters A; Brenner H
    Nat Commun; 2017 Mar; 8():14617. PubMed ID: 28303888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Id-protein family in developmental and cancer-associated pathways.
    Roschger C; Cabrele C
    Cell Commun Signal; 2017 Jan; 15(1):7. PubMed ID: 28122577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of STAT3 pathway in genitourinary tumors.
    Santoni M; Conti A; Piva F; Massari F; Ciccarese C; Burattini L; Cheng L; Lopez-Beltran A; Scarpelli M; Santini D; Tortora G; Cascinu S; Montironi R
    Future Sci OA; 2015 Nov; 1(3):FSO15. PubMed ID: 28031890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis.
    Leyh B; Dittmer A; Lange T; Martens JW; Dittmer J
    Oncotarget; 2015 Nov; 6(36):39307-28. PubMed ID: 26515727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.